1887

Abstract

Surmmary

Bronchial secretions of patients with cystic fibrosis (CF) inevitably become colonised with . This organism often exhibits multiple phenotypes with different antibiotic susceptibility profiles. Isolating each colonial morphotype and determining its antibiotic susceptibility profile is labour-intensive and time-consuming. Two disk diffusion methods for mixed morphotype susceptibility testing were examined; 134 morphotypes of from 50 respiratory specimens from CF patients were tested. Mixed cultures were prepared by (a) combining morphologically different colonies of directly from the sputum specimen primary culture plates from individual patients or (b) mixing colonies of individual morphotypes after isolation and subculture. Agreement with the results for testing morphotypes individually were 85.8% and 91.6%, respectively, for the two methods. These agreement rates rose to 95.6% and 99.4%, respectively, when minor errors (intermediate misclassified as susceptible or resistant or ) were excluded. Mixed morphotype testing of directly from sputum specimen culture plates in chronically colonised CF patients is more efficient, reduces turn-around time and provides clinically meaningful information about antibiotic susceptibility.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-42-3-220
1995-03-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/42/3/medmicro-42-3-220.html?itemId=/content/journal/jmm/10.1099/00222615-42-3-220&mimeType=html&fmt=ahah

References

  1. Fyfe J. A. M., Govan J. R. W. Chromosomal loci associated with antibiotic hypersensitivity in pulmonary isolates of Pseudomonas aeruginosa. J Gen Microbiol 1984; 130:825–834
    [Google Scholar]
  2. Thomassen M. J., Demko C. A., Boxerbaum B., Stern R. C., Kuchenbrod P. J. Multiple isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. J Infect Dis 1979; 140:873–880
    [Google Scholar]
  3. Seale T. W., Thirkill H., Tarpay M., Flux M., Rennert O. M. Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients. J Clin Microbiol 1979; 9:72–78
    [Google Scholar]
  4. Dunne W. M., Chusid M. J. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis. Diagn Microbiol Infect Dis 1987; 6:165–170
    [Google Scholar]
  5. Van Horn K. G. Mixed-morphotype broth microdilution sus ceptibility testing of Pseudomonas aeruginosa from cystic fibrosis patients. J Clin Microbiol 1993; 31:458–459
    [Google Scholar]
  6. Phillips I. Identification of Pseudomonas aeruginosa in the clinical laboratory. J Med Microbiol 1969; 2:9–16
    [Google Scholar]
  7. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disc susceptibility tests. 4th edn Document M2-A4, National Committee for Clinical Laboratory Standards; Villanova, PA: 1992
    [Google Scholar]
  8. National Committee for Clinical Laboratory Standards Zone diameter interpretive standards and equivalent minimum inhibitory concentration (MIC) breakpoints for organisms other than Haemophilus and Neisseria gonorrhoeae. Document M100-S3 M2-A4, National Committee for Clinical Laboratory Standards; Villanova, PA: 1992
    [Google Scholar]
  9. Bingen E., Denamur E., Picard B. Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1992; 11:432–437
    [Google Scholar]
  10. Glass S., Hayward C., Govan J. R. W. Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis. J Pediatr 1988; 113:76–79
    [Google Scholar]
  11. Govan J. R. W., Doherty C., Glass S. Rational parameters for antibiotic therapy in patients with cystic fibrosis. Infection 1987; 15:300–307
    [Google Scholar]
  12. Cullen R. T., McCrae W. M., Govan J., Raeburn J. A., Ingram T. M. Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies. J Antimicrob Chemother 1983; 12: Suppl A 369–375
    [Google Scholar]
  13. Lietman P. S. Pharmacokinetics of antimicrobial drugs in cystic fibrosis β-lactan antibiotics. Chest 1988; 94: Suppl 115S–119S
    [Google Scholar]
  14. Smith A. L. Antibiotic resistance is not relevant in infections in cystic fibrosis. Pediatr Pulmon 1990; 9: S5 93
    [Google Scholar]
  15. Valerius N. H., Koch C., Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338:725–726
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-42-3-220
Loading
/content/journal/jmm/10.1099/00222615-42-3-220
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error